ReproCell Akcia

ReproCell EV/OCF

EV/OCF (Podniková hodnota k operačnému cashflow) spoločnosti ReproCell (4978.T) k 16. 8. 2026 je 1 830,09. V predchádzajúcom roku EV/OCF (Podniková hodnota k operačnému cashflow) bolo -775,59 — zmena o -335,96 % (vyššie).

EV/OCF

1 830,09

YoY

-335,96%

Naposledy aktualizované:

EV/OCF (Podniková hodnota k operačnému cashflow) spoločnosti ReproCell je 2026 1 830,09 . EV/OCF (Podniková hodnota k operačnému cashflow) spoločnosti ReproCell bolo 2025 -775,59 . Klesá teda o -335,96% vyššie oproti predchádzajúcemu roku.
Access this data via the Eulerpool API

ReproCell Analýza akcií

Čo robí ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je jednou z najobľúbenejších spoločností na Eulerpool.

Často kladené otázky o akcii ReproCell

EV/OCF (Podniková hodnota k operačnému cashflow) spoločnosti ReproCell je 1 830,09 v roku 2026.

EV/OCF (Podniková hodnota k operačnému cashflow) spoločnosti ReproCell sa zmenil z -775,59 na 1 830,09, čo predstavuje zmenu -335,96 %. Hodnota je vyššie ako v predchádzajúcom roku.

Na Eulerpool nájdete kompletnú historickú evolúciu ReproCell EV/OCF (Podniková hodnota k operačnému cashflow) od roku 2006 – s ročnými hodnotami, grafmi a detailnou analýzou.

EV/OCF porovnáva podnikovú hodnotu s operačným cashflowom a meria, koľko investori platia na jednotku hotovosti generovanej z operácií.

Aby ste vyhodnotili EV/OCF (Podniková hodnota k operačnému cashflow)s, je nevyhnutné to porovnať so spoločnosťami v rovnakom odvetví a sektore. Na Eulopoole nájdete priame porovnania medzi spoločnosťami v odvetví pre EV/OCF (Podniková hodnota k operačnému cashflow).

Dobrá hodnota sa líši v závislosti od odvetvia a fázy vývoja spoločnosti. Na Eulopoole môžete porovnať EV/OCF (Podniková hodnota k operačnému cashflow)s ReproCell s konkurentmi v sektore a priemerom odvetvia, aby ste posúdili, či je atraktívna.

Access this data via the Eulerpool API

Oceňovanie — ReproCell

Všetky kľúčové ukazovatele — ReproCell